Cargando…
An Update on Self-Amplifying mRNA Vaccine Development
This review will explore the four major pillars required for design and development of an saRNA vaccine: Antigen design, vector design, non-viral delivery systems, and manufacturing (both saRNA and lipid nanoparticles (LNP)). We report on the major innovations, preclinical and clinical data reported...
Autores principales: | Blakney, Anna K., Ip, Shell, Geall, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911542/ https://www.ncbi.nlm.nih.gov/pubmed/33525396 http://dx.doi.org/10.3390/vaccines9020097 |
Ejemplares similares
-
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013) -
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
por: Blakney, Anna K., et al.
Publicado: (2021) -
Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
por: Schmidt, Christin, et al.
Publicado: (2023) -
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
por: Magini, Diletta, et al.
Publicado: (2016) -
Reinventing the nucleic acid vaccine with self-amplifying RNA
por: Geall, AJ, et al.
Publicado: (2012)